Clinical Trials Directory

Trials / Completed

CompletedNCT01550432

Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation

Effects of GSH and N-Acetylcysteine on Inflammatory Markers Among Adults With CVD Risk

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The rationale for the potential role of antioxidants in the prevention of cardiovascular diseases (CVD) remains strong despite the disappointing results of recent trials with a few select antioxidant vitamins. Glutathione (GSH) is one of the body's most powerful antioxidant agents but there is a surprising paucity of data on its use as an interventional therapy. Glutathione, when taken orally, is immediately broken down into its constituent amino acids, of which cysteine is the only one to be essential. Available cysteine is the critical determinant of intracellular GSH concentrations. N-acetyl cysteine (NAC) is an antioxidant supplement that has been used to provide a source of cysteine to replete GSH levels. By replenishing endogenous glutathione, it is possible that NAC would exert the same effect(s) as exogenous GSH. However, there is a new delivery system, liposomal GSH, which keeps glutathione intact. In this study, the investigators propose to match the cysteine content of NAC and GSH and compare the effects of these two supplements, at two different doses, on markers of inflammation and oxidative stress.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGlutathione1,130 mg/day or 2,260 mg/day for 8 weeks
DIETARY_SUPPLEMENTN-Acetylcysteine600 mg/day or 1,200 mg/day for 8 weeks
OTHERPlaceboVolume of liquid placebo product comparable to liposomal glutathione and 1 or 2 placebo pills/day.

Timeline

Start date
2011-06-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2012-03-12
Last updated
2023-02-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01550432. Inclusion in this directory is not an endorsement.